ReviewCanadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
A review of features and characteristics of smart medication adherence products.
Review in Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Evaluation of Hospice@Home for Home-Based Palliative Care: Development and Usability Pilot Study.JMIR formative research · 2026Article
- Assessment tools for medication self-management capacity in community-dwelling older adults with sensory impairment: a scoping review.BMC geriatrics · 2025Article
- Older adults' preferences for features of medication adherence technologies: a preference elicitation study.BMC digital health · 2025Article
- Exploring Older Adults' Perspectives on Digital Home Care Interventions and Home Modifications: Focus Group Study.JMIR formative research · 2024Article
- Designing for medication adherence in inflammatory bowel disease: multi-disciplinary approaches for self-administrable biotherapeutics.EClinicalMedicine · 2024Review
- Article
- Navigating the Metaverse: A New Virtual Tool with Promising Real Benefits for Breast Cancer Patients.Journal of clinical medicine · 2024Review
- Reducing the Burdens of Paid Caregivers of Older Adults by Using Assistive Technology: A Scoping Review.Western journal of nursing research · 2024Article
- Usability of an automated medication dispensation device and adherence dashboard: A study protocol.PloS one · 2024Article
- Article
- Exploring the Value of Real-Time Medication Adherence Monitoring: A Qualitative Study.Pharmacy (Basel, Switzerland) · 2023Article
- Future opportunities for research in rescue treatments.Epilepsia · 2022Review
- An In-Home Medication Dispensing System to Support Medication Adherence for Patients With Chronic Conditions in the Community Setting: Prospective Observational Pilot Study.JMIR formative research · 2022Article
- Technologies for Medication Adherence Monitoring and Technology Assessment Criteria: Narrative Review.JMIR mHealth and uHealth · 2022Review
- Article
- Medication nonadherence: Time for a proactive approach by pharmacists.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPCArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSmart medication adherence products (smart MAPs) capture and transmit real-time medication intake by using various means of connectivity, allowing for remote monitoring. Numerous such products with different features are available to address medication nonadherence. A comparison of the features of these products is needed for clinical decision-making. Therefore, the objective of this review was to compare smart MAPs available for in-home use.
methodsWe searched grey and published literature and videos to identify smart MAPs. To be considered smart, products required 2 features: connectivity (the ability for collected data to exist outside the physical device) and automaticity (the ability for data to be analyzed or processed automatically). Products were excluded if product descriptions were not available in English, not for in-home use and unable to dispense medications.
resultsOf the 51 products identified, 38 commercially available and 13 prototypes met the definition. Of these, 75% ( DISCUSSION: There is a growing market of smart MAPs for in-home patient use with variable features. Clinicians can use these features to identify and recommend products according to the specific needs of their patients to address medication adherence.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.